Medicines Discovery Catapult UK upgrade to MOLECUBES preclinical PET/CT system
29 July 2021
Medicines Discovery Catapult (MDC), headquartered at Alderley Park, UK, recently decided to upgrade its preclinical imaging platform with the addition of a state-of-the-art modular benchtop preclinical PET/CT system.
Accelerating translational research in the UK
This will help to enable the UK SME community access advanced preclinical imaging technologies and as such have a significant impact on accelerating translational research and new drug discovery.
MOLECUBES partners in the UK and US
LabLogic's sister company Southern Scientific works closely with MOLECUBES to ensure continuity in the UK in these challenging times. Both LabLogic and Southern Scientific are knowledgeable and experienced partners to carry out installations and provide training and support when customers need it in the UK and US.